mtmt
The Hungarian Scientific Bibliography
XML
JSON
Public search
Magyarul
International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts
English Scientific
Published: , 226 p.
2025
Conference:
HUPHAR 2025 2025-06-04 [Mátraháza, Hungary]
Identifiers
MTMT: 36196397
Full text:
https://www.altagra.hu/wp-content/uploads/2025/06/HUPHAR2025_Programfuzet-A4_final_08_jav.pdf
Chapters
Péter Bátor Kemenesi-Gedei et al. MODULATORY EFFECT OF VITAMIN D3 ON NEUROIMMUNE, ANTIOXIDANT, AND PAIN-RELAT- ED GENE EXPRESSION IN A RAT MODEL OF OROFACIAL INFLAMMATION. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts
Rózsa Enikő et al. Genistein Inhibits the activation of Transient Receptor Potential Vanilloid-1 and Ankryn-1 ion channels in in vitro, in silico and in vivo pain mouse models. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts p. 15.
Magó Éva et al. HISTONE MODIFICATIONS AS KEY REGULATORS OF CANCER PROGRESSION AND GENE EXPRESSION. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts p. 42
Biskup Dóra et al. In silico and in vitro comparison of small molecule SST4 agonists. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 51-51
Hegedűs I. Zsombor et al. THE NOVEL GIP/GLP-1-RECEPTOR CO-AGONIST TIRZEPATIDE PRESERVES CARDIAC FUNCTION AND ENHANCES SURVIVAL IN ANGIOTENSIN II-INDUCED HEART FAILURE MODEL IN MICE. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 52-52
Dima Fayiz Barakat Alsou’b et al. PROTECTIVE ROLE OF MITOCHONDRIAL UNCOUPLING PROTEIN-2 IN ACUTE NEUROGENIC INFLAMMATORY PAIN: POTENTIAL LINKS WITH TRPV1 AND TRPA1 IN SENSORY NEURONS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 53-53
Kovácsházi Csenger et al. INFARCTSIZE-AI: AN EFFICIENT PRECLINICAL INFARCT SIZE IMAGE ANALYSIS TOOL. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 54-55
Topolcsányi Petronella et al. INVESTIGATION OF NOTCH SIGNALING IN THE REGULATION OF SURVIVAL AND DRUG SENSITIVITY IN SMALL CELL LUNG CANCER. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts p. 61
Rita Börzsei et al. Calculation of structural and thermodynamic stability of a- and b-cyclodextrin complexes. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts p. 77.
Alexandra Á. Benő et al. Epigenetic Alterations in Low-Grade and High-Grade Lung Tumors. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts p. 80
Görbe Anikó et al. DEVELOPMENT OF MIRNA THERAPEUTICS FOR CARDIOPROTECTION: THE EXAMPLES OF MIR-125B* AND MIR-140A.. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 91-91
Ágg Bence et al. DEVELOPMENT AND ASSESSMENT OF NOVEL STATISTICAL, NETWORK THEORETICAL AND MACHINE LEARNING-BASED METHODOLOGIES IN PHARMACOVIGILANCE. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 95-95
Schreckenberg Rolf et al. MRNA-BASED SARS-COV-2 VACCINES: THE INTRACELLULAR AGGREGATION OF ENCODED SPIKE MONOMERS AND THEIR SUBUNITS AS A CAUSE OF CARDIAC SIDE EFFECTS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 114-114
Varga Zoltán. IMMUNE CHECKPOINTS AND CARDIAC DISEASES. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 119-119
Zsidai Anna et al. THE SELECTIVE CYCLOOXYGENASE-2 INHIBITOR ETORICOXIB CAUSES DYSBIOSIS IN THE RAT. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 129-129
Zádori Zoltán S. et al. NSAID ENTEROPATHY IS ASSOCIATED WITH CHANGES IN HOST-MICROBE INTERACTION MEDIATORS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 131-131
Kocsis Márton et al. THYMIC MODULATION AS A POTENTIAL STRATEGY TO MITIGATE IMMUNE CHECKPOINT INHIBITOR CARDIOTOXICITY. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 139-139
Kovács Andrea et al. TIME DEPENDENT MOLECULAR AND CELLULAR ALTERATIONS IN IRON HOMEOSTASIS AFTER ISCHEMIC INJURY OF MYOCARDIUM. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 140-140
Szabó Márta et al. CARDIOPROTECTIVE MICRORNAS (PROTECTOMIRS) IDENTIFIED IN A PORCINE MODEL OF ACUTE MYOCARDIAL INFARCTION AND ISCHEMIC CONDITIONING: IN VITRO VALIDATION OF NOVEL CANDIDATES. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 141-141
Papp Lilla et al. PHARMACOKINETIC AND PHARMACODYNAMIC CHARACTERIZATION OF MICRORNA-125B* FOLLOWING INTRAVENOUS ADMINISTRATION IN AN IN VIVO MOUSE MODEL. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 142-142
Jezsoviczky Sára et al. A NEW THERAPEUTIC APPROACH IN HEART FAILURE: A CELL-BASED PLATFORM FOR TESTING INFLAMMASOME INHIBITORS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 143-143
Alhaddad Ayham R et al. INFLAMMAGING: IMPACT OF INFLAMMATION ON CARDIOPULMONARY DECLINE IN OLD MICE. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 145-145
Mórotz Gábor M. et al. DAMAGES TO THE ENDOPLASMIC RETICULUM-MITOCHONDRIA INTERACTION IN A TYPE-2 MYOCARDIAL INFARCTION MODEL. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 146-146
Nagy Regina et al. COX-2 INHIBITION INDUCES GENE EXPRESSION CHANGES THAT SURPRISINGLY IMPROVE CAR- DIAC FUNCTION IN RATS WITH HYPERCHOLESTEROLEMIA. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 147-147
Nagy Dávid et al. MULTIORGAN CHARACTERIZATION OF INFLAMMASOME EXPRESSION IN A RAT MODEL OF ADVANCED HEART FAILURE. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 148-148
Szabó Lilla et al. DOWNREGULATION OF VIRAL RESTRICTION FACTORS IN HEART FAILURE. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 150-150
Abbood Sarah K. et al. THE ANTIALLODYNIC EFFECT OF PHENYLEPHRINE ALONE OR COMBINED WITH PREGABALIN IN RATS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 151-151
Boldizsár Imre Jr et al. THE ROLE OF ANGIOTENSIN II RECEPTOR TYPE 1 AND PPARγ IN OPIOID ANALGESIC TOLERANCE. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 152-152
Haghighi Samaneh et al. DOSE-DEPENDENT EFFECTS OF NSAIDs ON AUTOPHAGY AND OXIDATIVE STRESS IN HUMAN RENAL EPITHELIAL CELLS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 162-162
Haghighi Arezoo et al. FLAGELLIN PRETREATMENT AMELIORATES INDOMETHACIN-INDUCED ENTEROPATHY IN MICE. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 164-164
Jakab Márk E. et al. Characterization of a Mouse Model of Clozapine-Induced Myocarditis. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 165-165
Ritter Emese et al. MITOCHONDRIAL UNCOUPLING PROTEIN 2 REGULATES LUNG AND HEART FUNCTIONS, AND PROTECTS AGAINST INFLAMMATORY DYSFUNCTIONS IN FEMALE RATS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 166-166
Bózsity-Faragó Noémi et al. ANTIPROLIFERATIVE EFFECT OF NEW STEROID AND PROTOFLAVONOID COMPOUNDS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts p. 168
Wachtl Gerda et al. INVESTIGATION OF THE ROLE OF ANANDAMIDE IN NSAID ENTEROPATHY IN MICE. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 170-170
Essmat Nariman et al. DELAYING MORPHINE-INDUCED ANTINOCICEPTIVE TOLERANCE AND CONSTIPATION IN RATS BY PREGABALIN OR NALOXONE. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 173-173
Varga Bence Tamás et al. CHALLENGES AND LESSONS IN DEVELOPING A PHARMACOLOGICALLY-INDUCED NEUROVASCULAR UNCOUPLING MODEL IN RATS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 181-181
Chalabiani Yashar et al. INVESTIGATION OF THE MECHANISM OF ACTION OF ENHANCER SUBSTANCE VIA TAAR1. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 183-183
Görögh Panna et al. The interplay of PACAP-38 and metabolic biomarkers in saliva: A novel non-invasive approach to insulin regulation. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts p. 192
Kulin Anna et al. SPATIAL INVESTIGATION OF IMMUNE CHECKPOINT INHIBITOR INDUCED GENE EXPRESSION ALTERATIONS IN THE THYMUS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 201-201
Balogh Olivér et al. A DEEP GENERATIVE MODEL IMPROVED BY COMPUTER VISION PRE-PROCESSING TECHNIQUES TO PREDICT PROTEIN–PROTEIN INTERACTIONS BASED ON NETWORK TOPOLOGY. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 204-204
Kapui Dóra et al. TRANSLATION OF COMBINED DENSITY GRADIENT ULTRACENTRIFUGATION AND SIZE EXCLUSION CHROMATOGRAPHY-BASED EV ISOLATION FROM RAT TO HUMAN PLASMA FOR METABOLOMIC AND PROTEOMIC ANALYSES. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 205-205
Váczy-Földi Máté et al. EXPLORING CARDIOPROTECTIVE MICRORNA FAMILIES ACROSS SPECIES USING BIOINFORMATICS ANALYSIS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 206-206
Larose Angelique et al. DEVELOPING REPORTERS FOR MONITORING SARCO/ENDOPLASMIC RETICULUM-MITOCHONDRIA INTERACTIONS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 209-209
Szabados Tamara et al. CHALLENGES IN THE PRECLINICAL DEVELOPMENT OF MICRORNA THERAPEUTICS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 210-210
Makolli Amir et al. SPACEFLIGHT AND MICROGRAVITY MODELS CHANGE PHARMACOKINETICS AND PHARMACODYNAMICS: A SYSTEMATIC REVIEW AND META-ANALYSIS. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 211-211
Rácz Richárd et al. MESENCHYMAL STEM CELL DERIVED EXTRACELLULAR VESICLES FUNCTIONAL STUDY AND THEIR UTILIZATION FOR THE REDUCTION OF CHEMOTHERAPEUTICS CAUSED CARDIOTOXICITY. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 219-219
Zsuzsanna Schelz et al. Drug Repositioning for Cancer Therapy: An Overview of in Vitro Oncopharmacological Findings with Drugs Designed Originally for Cardiovascular and Metabolic Diseases. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 221-221
Hambalkó Szabolcs et al. DIFFERENCES IN THE PROPERTIES OF MSC-EVS TO REDUCE THE CARDIAC SIDE EFFECTS OF THE ANTI-CANCER DRUG. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 222-222
Makkos András et al. EFFECT OF A COMBINATION OF SELECTIVE CDK12 AND PARP INHIBITORS ON PARP INHIB- ITOR RESISTANT BREAST CANCER CELL LINES. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 223-223
Somogyi Orsolya et al. ANTITUMOUR ACTIVITY OF THIOUREAS IN BREAST CANCER. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 225-225
Kovács Tamás et al. THE COMBINED USE OF IMMUNE CHECKPOINT INHIBITORS AND OLAPARIB TO REDUCE CARDIOTOXIC SIDE EFFECTS AND POTENTIATE ANTI-CANCER TREATMENT. (2025) In: International Pharmacology Conference: focus on drug discovery and innovation (HUPHAR 2025) : Oral & Poster Abstracts pp. 226-226
Citation styles:
IEEE
ACM
APA
Chicago
Harvard
CSL
Copy
Print
2026-01-21 11:02
×
Export list as bibliography
Citation styles:
IEEE
ACM
APA
Chicago
Harvard
Print
Copy
